PCM
MDGL icon

Penserra Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Penserra Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-954
Closed -$437K – 1112
2025
Q3 		$437K Buy
+954
New +$356K 0.01% 599
2021
Q4 		– Sell
-380
Closed -$30K – 1470
2021
Q3 		$30K Hold
380
– – ﹤0.01% 1180
2021
Q2 		$37K Buy
380
+15
+4% +$1.78K ﹤0.01% 1065
2021
Q1 		$42K Buy
365
+5
+1% +$583 ﹤0.01% 842
2020
Q4 		$40K Buy
+360
New +$44K ﹤0.01% 728

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return